Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,347.6
-1.1 (-0.03%)

 

  • STI Straits Times Index
    3,347.6
    -1.1 (-0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,622.1
    2.3 (0.14%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,963.3
    -161.4 (-0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,270.8
    20.6 (0.63%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,200.6
    110.4 (0.50%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,507.2
    25.7 (0.40%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,216.2
    2.4 (0.11%)
    Index delayed 20 minutes
  • XAO XAO
    6,349.9
    -0.4 (-0.01%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 674.7M
  • Value: 928.7M
  • Rise: 133
  • Fall: 191
  • Unch: 521

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing0.960-
TEE Intl0.113-0.001
Mapletree Log Tr1.440-
YZJ Shipbldg SGD1.600+0.010
Ascendas Reit2.940-
JCG Investment0.002-
Golden Agri-Res0.295-0.010
CapitaMall Trust2.310-0.020
Y Ventures0.135+0.016
ESR-REIT0.515-0.005

World Indices

World Indices
Name Last Change
Nasdaq 7,998.1 +2.0
HSI 29,963.3 -161.4
HSCEI 11,768.6 -80.3
Jakarta 6,507.2 +25.7
Nikkei 225 22,200.6 +110.4
SSE Comp 3,270.8 +20.6
Shanghai A 3,425.9 +21.6
Shanghai B 320.0 +1.0
ShenZhen A 1,860.5 +17.3
ShenZhen B 1,062.5 +3.5
Taiwan W 10,968.5 +6.5
PSE Comp 0.0
KOSPI 2,216.2 +2.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 18 Apr 2019 17:04
Last (SGD): 0.004 Change: -0.001 High: 0.004 Remarks: -
Change (%): -20.00 Low: 0.004
Open 0.004 Yesterday's Close 0.005
Buy Price 0.004 Sell Price 0.005
Buy Volume ('000) 5,173.6 Sell Volume ('000) 38,066.1
Cumulative Volume ('000) 4,482.0 Cumulative Value 17,928
 
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01923 Trailing EPS (SGD) e 0.01923 NAV (SGD) b 0.0115
PE a 0.208 Trailing PE f 0.208 Price / NAV b 0.3478
Dividend (SGD) d - Cash In Hand (SGD) g 0.0070 Issued & Paid-up Shares c 2,092,632,000
Dividend Yield (%) d - Price / Cash In Hand g 0.571 Treasury Shares h -
Beta - 75 Daysi 3.215 R-Squared - 75 Days(%)i 3.49 Market Cap (M) 8.371
Beta - 500 Daysi 0.960 R-Squared - 500 Days (%)i 0.92 Enterprise Value (M) -3.061
Piotroski F Score 4 Exchange Code 5I0 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 90.2039 6-Month VWAP 0.006 Free Float (%) 92.5
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 8.371 0.208 0.208 0.3478 -
Industry Biotechnology SGX 1,984.451 7.329 7.329 0.6875 4.753
Medical & Biotechnology SGX 1,025.230 22.861 22.872 1.3972 1.878
Index FTSE ST Catalist Index SGX 81.312 131.623 - 0.9313 2.238
Local Peer Lonza SGX 5,937.453 7.663 7.663 0.6889 4.766
Local Peer Suntar Eco-City^ SGX 7.531 - - 0.4286 -
Global Peer AMGEN INC NASDAQ 109,312.469 13.023 13.023 8.7450 3.041
Global Peer GILEAD SCIENCES INC NASDAQ 80,254.955 14.712 14.712 3.7525 3.642
Global Peer AMGEN-T HKEx 615,949.000 9.363 9.363 6.2937 4.230
Global Peer CELGENE CORP NASDAQ 65,861.712 16.278 16.278 10.6901 -
Global Peer CSL ASX 86,320.272 38.686 35.433 12.5243 1.197
Global Peer ILLUMINA INC NASDAQ 46,867.740 56.741 56.741 12.4715 -
Global Peer BIOGEN INC NASDAQ 44,532.951 10.051 10.051 3.4152 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 42,991.281 20.507 20.507 9.6932 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 36,426.512 14.902 14.902 4.1596 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 28,264.043 364.222 364.227 3.0838 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), EXACT SCIENCES CORP (NASDAQ), SEATTLE GENETICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), BEIGENE-B (HKEx), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), EXELIXIS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), 3SBIO (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), GENSCRIPT BIO (HKEx), TILRAY INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), REPLIGEN CORP (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), REGENXBIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), MYOVANT SCIENCES LTD (NYSE), EDITAS MEDICINE INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), NATERA INC (NASDAQ), EPIZYME INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RADIUS HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASCLETIS-B (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), OMEROS CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INTREXON CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), KURA ONCOLOGY INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), MESOBLAST LTD (ASX), SYNTHORX INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), LEE'S PHARM (HKEx), ACORDA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), AVROBIO INC (NASDAQ), AVITA MEDICAL LTD (ASX), REPLIMUNE GROUP INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRANSLATE BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PROTHENA CORP PLC (NASDAQ), POLYNOVO LIMITED (ASX), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MERUS B V (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), UNITY BIOTECHNOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), SAVARA INC (NASDAQ), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), INSYS THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), KAMADA (NASDAQ), NOVAVAX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), DPHARMA (Bursa), AFFIMED N V (NASDAQ), SYNLOGIC INC (NASDAQ), ATHERSYS INC (NASDAQ), COMPUGEN (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VBI VACCINES INC CDA (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CHIASMA INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NYSE American), NEON THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BBI LIFE SCI (HKEx), SYNDAX PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AVEO PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), VERASTEM INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), IMV INC (NASDAQ), TELIX PHARMACEUTIC (ASX), PIERIS PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), EDAP TMS S.A. ADS EACH REPR 1 ORD SHARE FRF0.8 (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PFENEX INC (NYSE American), BELLICUM PHARMACEUTICALS (NASDAQ), CHIMERIX INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), UNI-BIO GROUP (HKEx), ORGANOVO HLDGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), VERMILLION INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), INMUNE BIO INC (NASDAQ), ZAFGEN INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CATABASIS PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), CORREVIO PHARMA CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ORGENESIS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), PORT (SET), ALIMERA SCIENCES INC (NASDAQ), IMMUTEP LTD (ASX), CT ENTERPRISE (HKEx), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), RESAPP HEALTH LIMITED (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), AQUINOX PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), CURIS INC (NASDAQ), IVERIC BIO INC (NASDAQ), EVOGENE LTD (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), BIONOMICS LTD (ASX), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), IMUGENE LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), PHYLOGICA LIMITED (ASX), BIOTRON (ASX), HEAT BIOLOGICS INC (NASDAQ), ONCOMED PHARMACEUTICALS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PRECIPIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), VITAL THERAPIES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EXTRAWELL PHAR (HKEx), SOPHIRIS BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AEVI GENOMIC MEDIC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), GTX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ADVAXIS INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), VICAL INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), ORAGENICS INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), LEAP THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), RHINOMED LIMITED (ASX), BIOCEPT INC (NASDAQ), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), PATRYS LIMITED (ASX), HISTOGENICS CORP (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ADALTA LTD (ASX), NANOVIRICIDES INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), REGENEUS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), XENETIC BIOSCIENCES INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), TROVAGENE INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), SOLIGENIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), ALLIQUA BIOMEDICAL INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CELLMID LIMITED (ASX), HAO WEN HLDGS (HKEx), CYCLACEL PHARMA IN (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AURIS MEDICAL HOLD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), ORTHOCELL LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADR EA REPR 2 ORD SHS (NYSE American), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), OPGEN INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), PROTEON THERAPEUTICS INC (NASDAQ), BIOXYNE LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NEURALSTEM INC (NASDAQ), MEMPHASYS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), MGRC (Bursa), VAXART INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MEGASUN (Bursa), OHR PHARMACEUTICAL INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), STELLAR BIOTECHNOLOGIES INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), CYTORI THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), PHOSPHAGENICS LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), MEDIBIO LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX), AMPLIPHI BIOSCIENCES CORPORATION (NYSE American), ALCHEMIA LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), BPH ENERGY LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), GENERA BIOSYSTEMS LIMITED (ASX), SINOVAC BIOTECH (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.001
+33.33 %
10 Days ---
20 Days --0.002
-33.33 %
Medium Term Return 3 Months --0.004
-50.00 %
6 Months --0.008
-66.67 %
1 Year --0.011
-73.33 %
Long Term Return 2 Years --0.025
-86.21 %
3 Years --0.100
-96.15 %
Annualised Return Annualised --
-66.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.003 - 0.019 Change From 1 Year Low +0.001 % Change From 1 Year Low (%) +33.33
Change From 1 Year High -0.015 % Change From 1 Year High (%) -78.95
2 Years Range 0.003 - 0.040 Change From 2 Years Low +0.001 % Change From 2 Years Low (%) +33.33
Change From 2 Years High -0.036 % Change From 2 Years High (%) -90.00
5 Years Range 0.003 - 0.560 Change From 5 Years Low +0.001 % Change From 5 Years Low (%) +33.33
Change From 5 Years High -0.556 % Change From 5 Years High (%) -99.29
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -98.57 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.05 MB)
Part 2(0.10 MB)
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Apr 2019 0.004 0.004 0.004 0.004 4,482,000 0.0040
17 Apr 2019 0.004 0.005 0.004 0.005 6,094,500 0.0040
16 Apr 2019 0.004 0.005 0.004 0.004 18,335,500 0.0040
15 Apr 2019 0.004 0.005 0.004 0.004 18,231,300 0.0041
12 Apr 2019 0.003 0.004 0.003 0.004 9,203,000 0.0040
11 Apr 2019 0.003 0.003 0.003 0.003 370,000 0.0030
10 Apr 2019 0.003 0.004 0.003 0.003 1,700,000 0.0031
09 Apr 2019 0.003 0.004 0.003 0.004 1,689,000 0.0036
08 Apr 2019 0.004 0.004 0.004 0.004 723,000 0.0040
05 Apr 2019 0.004 0.004 0.004 0.004 4,409,000 0.0040
04 Apr 2019 0.004 0.004 0.003 0.004 4,900,300 0.0031
03 Apr 2019 0.003 0.004 0.003 0.004 1,660,000 0.0040
02 Apr 2019 0.003 0.003 0.003 0.003 1,602,300 0.0030
01 Apr 2019 0.003 0.004 0.003 0.003 3,788,500 0.0031
29 Mar 2019 0.004 0.004 0.003 0.003 11,240,000 0.0035
28 Mar 2019 0.005 0.005 0.004 0.004 106,455,900 0.0040
27 Mar 2019 0.005 0.005 0.004 0.004 1,850,000 0.0044
26 Mar 2019 0.005 0.005 0.005 0.005 8,088,000 0.0050
25 Mar 2019 0.005 0.006 0.004 0.005 69,542,500 0.0050
22 Mar 2019 0.006 0.006 0.006 0.006 28,900,400 0.0060
21 Mar 2019 0.006 0.007 0.006 0.006 83,452,700 0.0060
20 Mar 2019 0.006 0.006 0.006 0.006 800,000 0.0060
Summary
Current 2 Weeks
(05 Apr 2019 to 18 Apr 2019)		 0.004 0.005 0.003 0.004 65,237,300 -
Previous 2 Weeks
(22 Mar 2019 to 04 Apr 2019)		 0.006 0.006 0.003 0.004 238,027,900 -
4 Weeks from
(22 Feb 2019 to 21 Mar 2019)		 0.007 0.007 0.003 0.006 101,964,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.